The CAPTIM study

Lancet. 2003 Feb 22;361(9358):700-1; author reply 701. doi: 10.1016/S0140-6736(03)12578-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Abciximab
  • Angioplasty, Balloon, Coronary
  • Antibodies, Monoclonal / therapeutic use*
  • Emergency Medical Services
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Patient Transfer*
  • Poland
  • Time Factors
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Fibrinolytic Agents
  • Immunoglobulin Fab Fragments
  • Tissue Plasminogen Activator
  • Abciximab